Feb 12, 2019

Chugai Wins Second Prize in 21st NIKKEI Annual Report Awards

TOKYO, February 12, 2019 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that its “Annual Report 2017” published in March 2018 won Second Prize in the 21st NIKKEI Annual Report Awards.

Started by Nikkei Inc. in 1998, the NIKKEI Annual Report Awards are presented with the aim to further enhance and promote annual reports published by Japanese companies. This year, 112 companies participated and a Grand Prize, three Second Prizes, two Special Prizes, and 15 Honors were awarded. 

Chugai began integrated reporting from Annual Report 2012 and has made various efforts to promote a better understanding of its unique strengths and corporate value among a wide range of stakeholders. As a result, our report has continually earned high acclaim, receiving an award every year since 2012, and winning the Grand Prize for two consecutive years in 2014 and 2015. 

Chugai’s Annual Report 2017 was highly evaluated for being “composed of stories that enable understanding of the corporate value creation process and the issues that the company needs to tackle in the coming years,” and for “its power to attract investors and its high level of quality as an integrated report.”

Chugai will continue striving to disclose information in an easy-to-understand manner in order to help satisfy the needs of its many stakeholders.

“Annual Report 2017” can be viewed from the following page:


cover image


  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Tomoko Shimizu
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Toshiya Sasai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp
  • Like
  • Post
  • LINE it!
  • E-mail
Back to top